Increased 27-hydroxycholesterol production during luteolysis may mediate the progressive decline in progesterone secretion.

about

Increased 27-hydroxycholesterol production during luteolysis may mediate the progressive decline in progesterone secretion.

Item

http://www.wikidata.org/entity/Q46253871

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Increased 27-hydroxycholestero ...... ine in progesterone secretion.

@en

Increased 27-hydroxycholestero ...... ine in progesterone secretion.

@nl

type

Item

label

Increased 27-hydroxycholestero ...... ine in progesterone secretion.

@en

Increased 27-hydroxycholestero ...... ine in progesterone secretion.

@nl

prefLabel

Increased 27-hydroxycholestero ...... ine in progesterone secretion.

@en

Increased 27-hydroxycholestero ...... ine in progesterone secretion.

@nl

P1476

Increased 27-hydroxycholestero ...... ine in progesterone secretion.

@en

P2093

José J Hernández-Ledezma

http://www.w3.org/2001/XMLSchema#string

Scot M Hutchison

http://www.w3.org/2001/XMLSchema#string

Yafei Xu

http://www.w3.org/2001/XMLSchema#string

P2860

cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism

LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes

Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells

Dynamics of circulating progesterone concentrations before and during luteolysis: a comparison between cattle and horses

Endocrine and local control of the primate corpus luteum

Oxysterol biosynthetic enzymes

The lutropin/choriogonadotropin receptor, a 2002 perspective

Treatment of Cushing's syndrome with trilostane (WIN 24,540), an inhibitor of adrenal steroid biosynthesis

The Lutropin/Choriogonadotropin Receptor, A 2002 Perspective

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

P304

2-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/MOLEHR/GAX061

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Randy L Bogan

P577

2017-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29177442

http://www.w3.org/2001/XMLSchema#string

P932

6093402

http://www.w3.org/2001/XMLSchema#string